Entera Stock Market Sentiment

ENTX
 Stock
  

USD 1.88  0.10  5.62%   

Entera investor sentiment overview provides quick insight into current market opportunities from investing in Entera Bio. The current market sentiment together Entera Bio's historical and current headlines can help investors to time the market. Many technical investors use Entera Bio stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Continue to Entera Bio Hype Analysis, Entera Bio Correlation and Entera Bio Performance.
  
Entera Bio stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Entera daily returns and investor perception about the current pice of Entera Bio as well as its diversification or hedging effects on your existing portfolios.

Entera Historical Sentiment

Although Entera Bio's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Entera, such as negative comments on social media and news outlets, may cause fear in the market and push Entera Bio's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Entera.
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Entera Bio's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Entera Bio.

Entera Bio Sentiment by Major News Outlets

benzinga news
Macroaxis News: globenewswire.com

Entera Bio Historical Investor Sentiment

Investor biases related to Entera Bio's public news can be used to forecast risks associated with investment in Entera. The trend in average sentiment can be used to explain how an investor holding Entera can time the market purely based on public headlines and social activities around Entera Bio. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Entera Bio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Entera Bio's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Entera Bio's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Entera Bio.

Entera Bio Twitter Pulse

Investors have realized that leveraging social media to get the fastest information affecting stock prices isn't a theory anymore, it is a reality, and Twitter offers a platform that can outpace even the most trustworthy news aggregators. The influence of social media outlets on stock markets and stock prices of entities such as Entera Bio has been proven in recent years. We extract public sentiment from Twitter posts that could be utilized to determine whether Entera Bio's prices will increase or decrease.
Twitter's metrics such as likes, followers, and engagement can be good indicators of the reliance and probability of reaction to a specific tweet regarding Entera Bio. Our Twitter sentiment analysis of Entera Stock helps investors make informed decisions by leveraging the power of the community. It is a perfect supplementary tool for any beginner or an experienced trader.
over two weeks ago at www.benzinga.com         
5.1 Million Bet On Tabula Rasa HealthCare 3 Penny Stocks Insiders Are Buying - Benzinga - Benzinga
benzinga news
over two weeks ago at www.macroaxis.com         
Entera Bio exotic insider transaction detected
Macroaxis News
over three weeks ago at www.marketscreener.com         
ENTERA BIO LTD. Change in Directors or Principal Officers - Marketscreener.com
Macroaxis News: marketscreener.com
over a month ago at finance.yahoo.com         
Entera Bio Announces Departure of Dr. Phillip Schwartz, the Companys President of Research Developme...
Yahoo News
over two months ago at www.streetinsider.com         
Form 424B3 Entera Bio Ltd. - StreetInsider.com
Street Insider News
over two months ago at www.defenseworld.net         
Analysts Anticipate The Wendys Company Will Post Earnings of 0.22 Per Share - Defense World
news
over two months ago at www.defenseworld.net         
-0.16 Earnings Per Share Expected for Entera Bio Ltd. This Quarter - Defense World
news
over two months ago at seekingalpha.com         
Entera Bio Ltd. CEO Spiros Jamas on Q1 2022 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha News
over two months ago at finance.yahoo.com         
Entera Bio Board Member, Miranda Toledano, to Assume Role of Chief Business Officer, Chief Financial...
Yahoo News
over three months ago at finance.yahoo.com         
Entera Bio Reports First Quarter 2022 Financial Results and Business Highlights - Yahoo Finance
Yahoo News
over three months ago at finance.yahoo.com         
Entera Bio Files Patent Applications for Inventions that Optimize its Platform Technology for Oral D...
Yahoo News
over three months ago at www.defenseworld.net         
Entera Bio Ltd. Sees Large Decline in Short Interest - Defense World
news
over three months ago at www.irishemigrant.com         
Hypoparathyroidism Treatment Market Size 2022-2029 Key Players AbbVie, Entera Bio, GlaxoSmithKline, ...
news
over three months ago at www.defenseworld.net         
Zacks Analysts Expect Entera Bio Ltd. to Announce -0.16 Earnings Per Share - Defense World
news
over three months ago at investorplace.com         
Recession Fears are Creating a Golden Opportunity for Biotech Stocks - InvestorPlace
sbwire news
Far too much social signal, news, headlines, and media speculation about Entera Bio that are available to investors today. That information is available publicly through Entera media outlets and privately through word of mouth or via Entera internal channels. However, regardless of the origin, that massive amount of Entera data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Entera Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Entera Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Entera Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Entera Bio alpha.

Entera Bio Performance against DOW

 Price Growth (%)  
       Timeline  
1
Financial Statements05/16/2022
2
Financial Statements05/27/2022
3
Entera Bio Announces Departure of Dr. Phillip Schwartz, the ...06/17/2022
4
Financial Statements07/18/2022
5
Entera Bio exotic insider transaction detected07/25/2022
6
5.1 Million Bet On Tabula Rasa HealthCare 3 Penny Stocks Ins...07/26/2022
7
Financial Statements08/01/2022
Continue to Entera Bio Hype Analysis, Entera Bio Correlation and Entera Bio Performance. Note that the Entera Bio information on this page should be used as a complementary analysis to other Entera Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Entera Stock analysis

When running Entera Bio price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Is Entera Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entera Bio. If investors know Entera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entera Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
52.4 M
Quarterly Revenue Growth YOY
-0.57
Return On Assets
-0.42
Return On Equity
-1.0
The market value of Entera Bio is measured differently than its book value, which is the value of Entera that is recorded on the company's balance sheet. Investors also form their own opinion of Entera Bio's value that differs from its market value or its book value, called intrinsic value, which is Entera Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entera Bio's market value can be influenced by many factors that don't directly affect Entera Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Entera Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Entera Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entera Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.